Indofarma Tbk (INAF) — Capital Reinvestment Ratio
Indofarma Tbk (INAF) has a Capital Reinvestment Ratio of 0.00x as of December 2024, meaning it reinvests 0% of its operating cash flow (Rp34.01 Billion) in capital expenditures (Rp6.94 Million). See Indofarma Tbk (INAF) balance sheet quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Indofarma Tbk Capital Reinvestment Ratio (2000–2021)
This chart tracks Indofarma Tbk's Capital Reinvestment Ratio across 14 annual periods. Check INAF capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Indofarma Tbk (2000–2021)
Year-by-year Capital Reinvestment Ratio for Indofarma Tbk from 2000 to 2021. For live market cap and broader valuation context, see Indofarma Tbk stock valuation.
| Year | Reinvestment Ratio | Operating CF (IDR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2021 | 0.23x | Rp92.90 Billion | Rp21.40 Billion | ▼ -22.2% |
| 2020 | 0.30x | Rp46.55 Billion | Rp13.78 Billion | ▲ +137.0% |
| 2019 | 0.12x | Rp20.79 Billion | Rp2.60 Billion | ▼ -80.6% |
| 2017 | 0.64x | Rp147.18 Billion | Rp94.87 Billion | ▲ +277.1% |
| 2015 | 0.17x | Rp134.28 Billion | Rp22.95 Billion | ▼ -54.6% |
| 2014 | 0.38x | Rp148.73 Billion | Rp56.05 Billion | ▲ +140.7% |
| 2011 | 0.16x | Rp29.40 Billion | Rp4.60 Billion | ▼ -33.3% |
| 2010 | 0.23x | Rp23.71 Billion | Rp5.57 Billion | ▼ -56.0% |
| 2009 | 0.53x | Rp40.56 Billion | Rp21.65 Billion | ▲ +1507.3% |
| 2007 | 0.03x | Rp83.42 Billion | Rp2.77 Billion | ▲ +44.4% |
| 2006 | 0.02x | Rp73.15 Billion | Rp1.68 Billion | ▲ +470.4% |
| 2004 | 0.00x | Rp159.25 Billion | Rp642.02 Million | ▼ -98.0% |
| 2003 | 0.21x | Rp40.70 Billion | Rp8.36 Billion | ▼ -89.2% |
| 2000 | 1.90x | Rp27.05 Billion | Rp51.43 Billion | — |